Sirtex Medical announces collaboration update with OncoSec Medical
Collaboration provides Sirtex the right to co-promote OncoSec lead product candidate TAVO™ for the treatment of advanced melanoma WOBURN, Massachusetts, Jan. 19, 2021 /PRNewswire/ -- Sirtex Medical US Holdings, Inc. ("Sirtex"), a leading manufacturer of targeted cancer therapies, announced an ad...
2021-01-19 22:00
6027